speb/financial-data huggingface dataset:
Financial ratios for BUT.L — annual report dated 2024-11-30
Total revenue: 124486075.94936708
Net income: 121583544.30379747
Capital expenditures: 0
Operating cash flow: 8245569.620253164
Net tangible assets: 782508860.7594936
Owner earnings: 121583544.30379747
Return on net tangible assets (%): 15.537657194806709
Buffett classification: The Gruesome
Stock price: 0.18
P/E ratio: 0.0636127305244089
Shares outstanding: 42968118
Book value: 782508860.7594936
P/B ratio: 0.009883928001138824
Market cap (USD): 7734261.239999999
Debt to equity: 0.056499542206016995
Effective tax rate (%): 1.371846344994712
COGS to revenue (%): 0
SG&A to revenue (%): 1.0137883348246972
Free cash flow (dilution-adjusted): 8245569.620253164
Buyback yield (%): 0
Receivables turnover: 18.14799778556929
Capitalized R&D asset: 0
FCF margin (%): 6.623688277881722
Revenue growth (%): 130.40653032796473
Rule of 40 score: 137.03021860584644
Financial ratios for BUT.L — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 782508860.7594936
Buffett classification: The Gruesome
Stock price: 0.18
Shares outstanding: 42968118
Book value: 782508860.7594936
P/B ratio: 0.009883928001138824
Market cap (USD): 7734261.239999999
Debt to equity: 0.056499542206016995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BUT.L — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 819214864.8648648
Buffett classification: The Gruesome
Stock price: 0.1837837837837838
Shares outstanding: 42968118
Market cap (USD): 7896843.308108108
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIC.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.018783783783783783
Shares outstanding: 59638588
Market cap (USD): 1120238.342162162
Buyback yield (%): 146.8075616319628
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIC.L — annual report dated 2022-09-30
Total revenue: 7843333.333333333
Gross profit: 2282222.222222222
Operating income: -885555.5555555555
Net income: -58888.88888888889
Capital expenditures: 1077777.7777777778
Operating cash flow: 4324444.444444444
Depreciation & amortization: 58888.88888888889
Net tangible assets: 138448888.8888889
Owner earnings: -1077777.7777777778
Return on net tangible assets (%): -0.7784661808609675
Buffett classification: The Gruesome
Stock price: 0.012999999999999998
Shares outstanding: 59638588
Book value: 138448888.8888889
P/B ratio: 0.005599912359153798
Market cap (USD): 775301.6439999999
Debt to equity: 0
Current ratio: 22.01121495327103
Quick ratio: 11.314018691588787
COGS to revenue (%): 70.90239410681399
SG&A to revenue (%): 40.38815696274259
Free cash flow (dilution-adjusted): 3246666.6666666665
Buyback yield (%): 0
Retained earnings: 130771111.1111111
Inventory turnover: 0.2915137748267226
Receivables turnover: 100.84285714285714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6097934200459068
FCF margin (%): 41.393965150871225
Rule of 40 score: 41.393965150871225
Financial ratios for CIC.L — annual report dated 2023-09-30
Total revenue: 17131707.31707317
Gross profit: -6196341.463414635
Operating income: -12019512.195121951
Net income: -36014634.146341465
Capital expenditures: 584146.3414634147
Operating cash flow: 6069512.195121951
Depreciation & amortization: 725609.756097561
Net tangible assets: 115941463.41463415
Owner earnings: -35873170.73170732
Return on net tangible assets (%): -30.940760686637496
Buffett classification: The Gruesome
Stock price: 0.011829268292682929
Shares outstanding: 59638588
Book value: 115941463.41463415
P/B ratio: 0.006084802082632111
Market cap (USD): 705480.8580487806
Debt to equity: 0.18091551666105687
Current ratio: 1.1136652094203918
Quick ratio: 0.6920039486673246
COGS to revenue (%): 136.16884965831434
SG&A to revenue (%): 33.990603644646924
Free cash flow (dilution-adjusted): 5485365.853658536
Buyback yield (%): 0
Retained earnings: 107514634.14634147
Inventory turnover: 6.397658862876254
Receivables turnover: 6.376758965047661
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.778680347726949
FCF margin (%): 32.01879271070615
Revenue growth (%): 118.4238076974905
Rule of 40 score: 150.44260040819665
Financial ratios for CIC.L — annual report dated 2024-09-30
Total revenue: 7921333.333333333
Gross profit: -564000
Operating income: -6650666.666666667
Net income: -44892000
Capital expenditures: 420000
Operating cash flow: -13340000
Depreciation & amortization: 837333.3333333334
Net tangible assets: 81870666.66666667
Owner earnings: -44474666.666666664
Return on net tangible assets (%): -54.3230786769376
Buffett classification: The Gruesome
Stock price: 0.009733333333333333
Shares outstanding: 59638588
Book value: 81493333.33333334
P/B ratio: 0.0071230643390052355
Market cap (USD): 580482.2565333333
Debt to equity: 0.9137761780104712
Current ratio: 0.3794999185535104
Quick ratio: 0.1594925883694413
COGS to revenue (%): 107.12001346574651
SG&A to revenue (%): 76.83891600740617
Free cash flow (dilution-adjusted): -13760000
Buyback yield (%): 0
Retained earnings: 72657333.33333333
Inventory turnover: 0.5889865802869043
Receivables turnover: 2.404289761230271
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.421628580624396
FCF margin (%): -173.7081299444538
Revenue growth (%): -53.76214882308277
Rule of 40 score: -227.47027876753657
Financial ratios for CIC.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 81870666.66666667
Buffett classification: The Gruesome
Stock price: 0.009733333333333333
Shares outstanding: 59638588
Book value: 81493333.33333334
P/B ratio: 0.0071230643390052355
Market cap (USD): 580482.2565333333
Debt to equity: 0.9137761780104712
Current ratio: 0.3794999185535104
Quick ratio: 0.1594925883694413
Buyback yield (%): 0
Retained earnings: 72657333.33333333
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIC.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 83248051.94805194
Buffett classification: The Gruesome
Stock price: 0.004415584415584416
Shares outstanding: 59638588
Book value: 82881818.18181819
P/B ratio: 0.0031772857487582067
Market cap (USD): 263339.21974025975
Debt to equity: 0.8524420627085978
Current ratio: 0.3316101331043366
Quick ratio: 0.15273507943323314
Buyback yield (%): 0
Retained earnings: 74274025.97402598
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIC.L — annual report dated 2025-09-30
Total revenue: 29579729.72972973
Gross profit: 11618918.918918919
Operating income: 4497297.297297297
Net income: -26414864.864864863
Capital expenditures: 1406756.7567567567
Operating cash flow: 17135135.135135137
Depreciation & amortization: 2397297.2972972975
Net tangible assets: 56560810.81081081
Owner earnings: -25424324.32432432
Return on net tangible assets (%): -44.95042408314418
Capex to operating income (%): 31.280048076923077
Buffett classification: The Good
Stock price: 0.003918918918918919
Shares outstanding: 59638588
Book value: 56179729.72972973
P/B ratio: 0.004160197849565824
Market cap (USD): 233718.7908108108
Debt to equity: 1.1549082337093788
Current ratio: 0.20454376854599404
Quick ratio: 0.1370734421364985
Interest coverage ratio: 0.768236380424746
COGS to revenue (%): 60.719996345196215
SG&A to revenue (%): 24.076019918680615
Free cash flow (dilution-adjusted): 15728378.378378378
Buyback yield (%): 0
Retained earnings: 47222972.972972974
Inventory turnover: 3.6533809785596487
Receivables turnover: 6.092123573615363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.06131975387227
FCF margin (%): 53.17282653387546
Revenue growth (%): 273.41857090215956
Rule of 40 score: 326.59139743603504
Financial ratios for CIC.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 56560810.81081081
Buffett classification: The Gruesome
Stock price: 0.003918918918918919
Shares outstanding: 59638588
Book value: 56179729.72972973
P/B ratio: 0.004160197849565824
Market cap (USD): 233718.7908108108
Debt to equity: 1.1549082337093788
Current ratio: 0.20454376854599404
Quick ratio: 0.1370734421364985
Buyback yield (%): 0
Retained earnings: 47222972.972972974
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLPT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.22
Shares outstanding: 29989563
Market cap (USD): 336482896.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLPT — annual report dated 2022-12-31
Total revenue: 20551000
Gross profit: 13531000
Operating income: -16332000
Net income: -16435000
Capital expenditures: 253000
Operating cash flow: -16167000
Depreciation & amortization: 777000
Net tangible assets: 35859000
Owner earnings: -15911000
Return on net tangible assets (%): -44.371008672857585
Buffett classification: The Gruesome
Stock price: 8.47
Shares outstanding: 29989563
Book value: 36887000
P/B ratio: 6.886209195922683
Market cap (USD): 254011598.61
Debt to equity: 0.3249383251552037
Current ratio: 7.539776075427224
Quick ratio: 6.169269298762522
Interest coverage ratio: -201.62962962962962
COGS to revenue (%): 34.1589217069729
R&D to revenue (%): 53.00958590822831
SG&A to revenue (%): 92.30207775777335
Free cash flow (dilution-adjusted): -21439000
Buyback yield (%): 0
Retained earnings: -150367000
Inventory turnover: 0.7545952918413416
Receivables turnover: 7.711444652908067
Capitalized R&D asset: 10894000
ROCI (R&D-adjusted, %): -15.218023581000963
FCF margin (%): -104.32095761763418
Rule of 40 score: -104.32095761763418
Financial ratios for CLPT — annual report dated 2023-12-31
Total revenue: 23955000
Gross profit: 13614000
Operating income: -22446000
Net income: -22089000
Capital expenditures: 717000
Operating cash flow: -13720000
Depreciation & amortization: 1457000
Net tangible assets: 20132000
Owner earnings: -21349000
Return on net tangible assets (%): -106.04510232465726
Buffett classification: The Gruesome
Stock price: 6.79
Shares outstanding: 29989563
Book value: 21173000
P/B ratio: 9.617396342983989
Market cap (USD): 203629132.77
Debt to equity: 0.6584329098380012
Current ratio: 4.868371467025572
Quick ratio: 3.8036339165545088
COGS to revenue (%): 43.168440826549784
R&D to revenue (%): 48.8791484032561
SG&A to revenue (%): 101.65309956167815
Free cash flow (dilution-adjusted): -20850000
Buyback yield (%): 0
Retained earnings: -172456000
Inventory turnover: 1.3071672354948805
Receivables turnover: 7.460292743693554
Capitalized R&D asset: 19007980
ROCI (R&D-adjusted, %): -33.686720018210764
Rosenberg metric: 0.007618872774004039
FCF margin (%): -87.03819661866
Revenue growth (%): 16.563670867597686
Rule of 40 score: -70.47452575106232
Financial ratios for CLPT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.21
Shares outstanding: 29989563
Market cap (USD): 336183001.23
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLPT — annual report dated 2024-12-31
Total revenue: 31390000
Gross profit: 19122000
Operating income: -19734000
Net income: -18914000
Capital expenditures: 275000
Operating cash flow: -8950000
Depreciation & amortization: 1903000
Net tangible assets: 25389000
Owner earnings: -17286000
Return on net tangible assets (%): -68.08460356847453
Buffett classification: The Gruesome
Stock price: 15.38
Shares outstanding: 29989563
Book value: 25389000
P/B ratio: 18.16690215999055
Market cap (USD): 461239478.94
Debt to equity: 0.14053330182362442
Current ratio: 3.222544190089829
Quick ratio: 2.559644547474162
Interest coverage ratio: -38.0965250965251
COGS to revenue (%): 39.0825103536158
R&D to revenue (%): 39.47754061803122
SG&A to revenue (%): 84.3071041733036
Free cash flow (dilution-adjusted): -16132000
Buyback yield (%): 0
Retained earnings: -191370000
Inventory turnover: 1.7875564621885474
Receivables turnover: 6.660301294292383
Capitalized R&D asset: 23832050
ROCI (R&D-adjusted, %): -36.088292617630614
Rosenberg metric: 0.4704073789392775
FCF margin (%): -51.39216310927047
Revenue growth (%): 31.037361719891464
Rule of 40 score: -20.354801389379006
Financial ratios for CLPT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.38
Shares outstanding: 29989563
Market cap (USD): 461239478.94
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLPT — quarterly report dated 2025-03-31
Total revenue: 8485000
Gross profit: 5132000
Operating income: -6163000
Net income: -6026000
Capital expenditures: 183000
Operating cash flow: -6172000
Depreciation & amortization: 334000
Net tangible assets: 19422000
Owner earnings: -5875000
Return on net tangible assets (%): -30.24920193594892
Buffett classification: The Gruesome
Stock price: 11.89
Shares outstanding: 29989563
Book value: 19987000
P/B ratio: 17.840391457947668
Market cap (USD): 356575904.07
Debt to equity: 0.17201180767498875
Current ratio: 3.5266530731138945
Quick ratio: 2.5680163122633264
COGS to revenue (%): 39.516794342958164
R&D to revenue (%): 39.82321744254567
SG&A to revenue (%): 93.29404832056571
Free cash flow (dilution-adjusted): -8263000
Buyback yield (%): 0
Retained earnings: -197396000
Inventory turnover: 0.5094196292920085
Receivables turnover: 2.3240208162147358
Capitalized R&D asset: 3379000
ROCI (R&D-adjusted, %): -14.709902318524367
FCF margin (%): -97.3836181496759
Rule of 40 score: -97.3836181496759
Financial ratios for CLPT — quarterly report dated 2025-06-30
Total revenue: 9215000
Gross profit: 5556000
Operating income: -5680000
Net income: -5837000
Capital expenditures: 91000
Operating cash flow: -2552000
Depreciation & amortization: 626000
Net tangible assets: 19743000
Owner earnings: -5302000
Return on net tangible assets (%): -26.85508787924834
Buffett classification: The Gruesome
Stock price: 11.94
Shares outstanding: 29989563
Book value: 19743000
P/B ratio: 18.136827342349186
Market cap (USD): 358075382.21999997
Debt to equity: 1.795877019703186
Current ratio: 7.298053527980535
Quick ratio: 6.447418221140849
Interest coverage ratio: -71
COGS to revenue (%): 39.7069994574064
R&D to revenue (%): 41.551817688551274
SG&A to revenue (%): 80.37981551817688
Free cash flow (dilution-adjusted): -4912000
Buyback yield (%): 0
Retained earnings: -203233000
Inventory turnover: 0.5814396948990942
Receivables turnover: 2.1631455399061035
Capitalized R&D asset: 6092930
ROCI (R&D-adjusted, %): -6.9093488129602285
Rosenberg metric: 0.12548091151228175
FCF margin (%): -53.304395008138904
Revenue growth (%): 8.603417796110783
Rule of 40 score: -44.70097721202812
Financial ratios for CLPT — quarterly report dated 2025-09-30
Total revenue: 8861000
Gross profit: 5600000
Operating income: -5276000
Net income: -5891000
Capital expenditures: 199000
Operating cash flow: -3121000
Depreciation & amortization: 426000
Net tangible assets: 15874000
Owner earnings: -5664000
Return on net tangible assets (%): -35.68098777875772
Buffett classification: The Gruesome
Stock price: 21.79
Shares outstanding: 29989563
Book value: 15874000
P/B ratio: 41.166220093864176
Market cap (USD): 653472577.77
Debt to equity: 2.2517953886859017
Current ratio: 6.373897926238669
Quick ratio: 5.556438594312678
Interest coverage ratio: -9.716390423572744
COGS to revenue (%): 36.80171538201106
R&D to revenue (%): 38.957228303803184
SG&A to revenue (%): 83.78286875070535
Free cash flow (dilution-adjusted): -5342000
Buyback yield (%): 0
Retained earnings: -209124000
Inventory turnover: 0.49536685401792496
Receivables turnover: 2.21525
Capitalized R&D asset: 7132500
ROCI (R&D-adjusted, %): -9.047190418906453
Rosenberg metric: 0.01149125097936798
FCF margin (%): -60.28664936237445
Revenue growth (%): -3.841562669560499
Rule of 40 score: -64.12821203193495
Financial ratios for CLPT — annual report dated 2025-12-31
Total revenue: 36971000
Gross profit: 22692000
Operating income: -24164000
Net income: -25540000
Capital expenditures: 522000
Operating cash flow: -23925000
Depreciation & amortization: 2237000
Net tangible assets: 6626000
Owner earnings: -23825000
Return on net tangible assets (%): -359.56836703893754
Buffett classification: The Gruesome
Stock price: 13.68
Shares outstanding: 29989563
Book value: 28020000
P/B ratio: 14.641585361884367
Market cap (USD): 410257221.84
Debt to equity: 2.0782298358315487
Current ratio: 5.908035299581979
Quick ratio: 5.131537389688806
Interest coverage ratio: -10.11892797319933
COGS to revenue (%): 38.622163317194556
R&D to revenue (%): 37.58892104622542
SG&A to revenue (%): 89.14825133212518
Free cash flow (dilution-adjusted): -32627000
Buyback yield (%): 0
Retained earnings: -216910000
Inventory turnover: 1.7082186864457471
Receivables turnover: 5.645289357153764
Capitalized R&D asset: 26063610
ROCI (R&D-adjusted, %): -20.286502058770793
Rosenberg metric: 0.2880890897353131
FCF margin (%): -88.25025019609964
Revenue growth (%): 17.779547626632684
Rule of 40 score: -70.47070256946697
Financial ratios for CLPT — quarterly report dated 2025-12-31
Total revenue: 10410000
Gross profit: 6404000
Operating income: -7045000
Net income: -7786000
Capital expenditures: 49000
Operating cash flow: -12080000
Depreciation & amortization: 851000
Net tangible assets: 6626000
Owner earnings: -6984000
Return on net tangible assets (%): -105.40295804406882
Buffett classification: The Gruesome
Stock price: 13.68
Shares outstanding: 29989563
Book value: 28020000
P/B ratio: 14.641585361884367
Market cap (USD): 410257221.84
Debt to equity: 2.0782298358315487
Current ratio: 5.908035299581979
Quick ratio: 5.131537389688806
Interest coverage ratio: -3.6769311064718164
COGS to revenue (%): 38.48222862632085
R&D to revenue (%): 31.095100864553316
SG&A to revenue (%): 98.09798270893371
Free cash flow (dilution-adjusted): -14110000
Buyback yield (%): 0
Retained earnings: -216910000
Inventory turnover: 0.4792439286996052
Receivables turnover: 1.5895556573522676
Capitalized R&D asset: 6813410
ROCI (R&D-adjusted, %): -7.797822942508594
Rosenberg metric: 0.23290845886442643
FCF margin (%): -135.5427473583093
Revenue growth (%): 17.481096941654442
Rule of 40 score: -118.06165041665486
Financial ratios for COCH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.74
Shares outstanding: 77021110
Market cap (USD): 750185611.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COCH — annual report dated 2022-12-31
Total revenue: 237000
Gross profit: -261000
Operating income: -8706000
Net income: -15923000
Capital expenditures: 218000
Operating cash flow: -8805000
Depreciation & amortization: 75000
Net tangible assets: -36195000
Owner earnings: -16066000
Buffett classification: The Gruesome
Stock price: 10.02
Shares outstanding: 77021110
Book value: -36195000
Market cap (USD): 771751522.1999999
Debt to equity: -0.9541373117833954
Current ratio: 0.6542278682016673
Quick ratio: 0.14013497419610957
COGS to revenue (%): 210.126582278481
R&D to revenue (%): 2099.15611814346
SG&A to revenue (%): 1464.1350210970463
Free cash flow (dilution-adjusted): -9023000
Buyback yield (%): 0
Retained earnings: -225985000
Inventory turnover: 0.38455598455598455
Receivables turnover: 5.780487804878049
Capitalized R&D asset: 4975000
ROCI (R&D-adjusted, %): -107.52859803139133
FCF margin (%): -3807.1729957805906
Rule of 40 score: -3807.1729957805906
Financial ratios for COCH — annual report dated 2023-12-31
Total revenue: 316000
Gross profit: -473000
Operating income: -18359000
Net income: -29922000
Capital expenditures: 153000
Operating cash flow: -17091000
Depreciation & amortization: 133000
Net tangible assets: -1776000
Owner earnings: -29942000
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 77021110
Book value: -1776000
Market cap (USD): 139408209.1
Debt to equity: -0.31644144144144143
Current ratio: 1.0234728894989704
Quick ratio: 0.8307481125600549
COGS to revenue (%): 249.68354430379748
R&D to revenue (%): 2834.1772151898736
SG&A to revenue (%): 2825.9493670886077
Free cash flow (dilution-adjusted): -18819000
Buyback yield (%): 0
Retained earnings: -257256000
Inventory turnover: 0.561965811965812
Receivables turnover: 1.2845528455284554
Capitalized R&D asset: 12289250
ROCI (R&D-adjusted, %): -105.81093890259443
Rosenberg metric: -0.042613065326633164
FCF margin (%): -5955.379746835443
Revenue growth (%): 33.33333333333333
Rule of 40 score: -5922.04641350211
Financial ratios for COCH — quarterly report dated 2024-09-30
Capital expenditures: 615000
Buffett classification: The Gruesome
Stock price: 3.25
Shares outstanding: 77021110
Market cap (USD): 250318607.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COCH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.43
Shares outstanding: 77021110
Market cap (USD): 110140187.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COCH — annual report dated 2024-12-31
Total revenue: 225000
Gross profit: -517000
Operating income: -19256000
Net income: -20795000
Capital expenditures: 980000
Operating cash flow: -17949000
Depreciation & amortization: 173000
Net tangible assets: -18842000
Owner earnings: -21602000
Buffett classification: The Gruesome
Stock price: 1.43
Shares outstanding: 77021110
Book value: -18842000
Market cap (USD): 110140187.3
Debt to equity: -1.0434667232777837
Current ratio: 1.1801538869726718
Quick ratio: 0.9535685858317856
Interest coverage ratio: -23.598039215686274
COGS to revenue (%): 329.77777777777777
R&D to revenue (%): 4524
SG&A to revenue (%): 3804.4444444444443
Free cash flow (dilution-adjusted): -19491000
Buyback yield (%): 0
Retained earnings: -284734000
Inventory turnover: 0.4344262295081967
Receivables turnover: 0.27506112469437655
Capitalized R&D asset: 17821270
ROCI (R&D-adjusted, %): -78.42653826595183
Rosenberg metric: -0.004912907548012505
FCF margin (%): -8662.666666666666
Revenue growth (%): -28.79746835443038
Rule of 40 score: -8691.464135021097
Financial ratios for COCH — quarterly report dated 2025-03-31
Total revenue: 46000
Gross profit: -180000
Operating income: -5107000
Net income: -4998000
Capital expenditures: 6000
Operating cash flow: -3725000
Depreciation & amortization: 61000
Net tangible assets: -24224000
Owner earnings: -4943000
Buffett classification: The Gruesome
Stock price: 1.3
Shares outstanding: 77021110
Book value: -24224000
Market cap (USD): 100127443
Debt to equity: -0.9919501321003963
Current ratio: 1.0944042132982226
Quick ratio: 0.8762343647136274
Interest coverage ratio: -10.317171717171718
COGS to revenue (%): 491.30434782608694
R&D to revenue (%): 5973.913043478261
SG&A to revenue (%): 4736.95652173913
Free cash flow (dilution-adjusted): -3891000
Buyback yield (%): 0
Retained earnings: -290970000
Inventory turnover: 0.1363910681955341
Receivables turnover: 0.7076923076923077
Capitalized R&D asset: 2748000
ROCI (R&D-adjusted, %): -59.1368725171542
FCF margin (%): -8458.695652173912
Rule of 40 score: -8458.695652173912
Financial ratios for COCH — quarterly report dated 2025-06-30
Total revenue: 78000
Gross profit: -156000
Operating income: -5070000
Net income: -5690000
Capital expenditures: 1000
Operating cash flow: -4460000
Depreciation & amortization: 85000
Net tangible assets: -29859000
Owner earnings: -5606000
Buffett classification: The Gruesome
Stock price: 1.42
Shares outstanding: 77021110
Book value: -29859000
Market cap (USD): 109369976.19999999
Debt to equity: -0.9656385009544861
Current ratio: 0.939125
Quick ratio: 0.74075
Interest coverage ratio: -8.125
COGS to revenue (%): 300
R&D to revenue (%): 3185.8974358974356
SG&A to revenue (%): 3114.1025641025644
Free cash flow (dilution-adjusted): -4607000
Buyback yield (%): 0
Retained earnings: -297912000
Inventory turnover: 0.14744801512287334
Receivables turnover: 1.2380952380952381
Capitalized R&D asset: 4326160
ROCI (R&D-adjusted, %): -69.53456598181435
Rosenberg metric: 0.008733624454148471
FCF margin (%): -5906.410256410256
Revenue growth (%): 69.56521739130434
Rule of 40 score: -5836.845039018952
Financial ratios for COCH — quarterly report dated 2025-09-30
Total revenue: 42000
Gross profit: -161000
Operating income: -5708000
Net income: -6482000
Capital expenditures: 0
Operating cash flow: -4331000
Depreciation & amortization: 76000
Net tangible assets: -7531000
Owner earnings: -6406000
Buffett classification: The Gruesome
Stock price: 0.78
Shares outstanding: 77021110
Book value: -7531000
Market cap (USD): 60076465.800000004
Debt to equity: -0.12561412826981808
Current ratio: 0.640520694259012
Quick ratio: 0.45816644414775254
Interest coverage ratio: -12.118895966029724
COGS to revenue (%): 483.3333333333333
R&D to revenue (%): 6428.571428571429
SG&A to revenue (%): 6778.571428571429
Free cash flow (dilution-adjusted): -4655000
Buyback yield (%): 0
Retained earnings: -305659000
Inventory turnover: 0.12385600976205004
Receivables turnover: 0.7777777777777778
Capitalized R&D asset: 5271790
ROCI (R&D-adjusted, %): -126.59796616040919
Rosenberg metric: -0.002012072434607646
FCF margin (%): -11083.333333333332
Revenue growth (%): -46.15384615384615
Rule of 40 score: -11129.487179487178
Financial ratios for COCH — quarterly report dated 2025-12-31
Total revenue: 75000
Gross profit: -136000
Operating income: -6385000
Net income: -6586000
Capital expenditures: 172000
Operating cash flow: -5685000
Depreciation & amortization: 80000
Net tangible assets: -11767000
Owner earnings: -6678000
Buffett classification: The Gruesome
Stock price: 0.66
Shares outstanding: 77021110
Book value: -11767000
Market cap (USD): 50833932.6
Debt to equity: -0.07809977054474378
Current ratio: 0.543072132848988
Quick ratio: 0.40935824251859537
COGS to revenue (%): 281.33333333333337
R&D to revenue (%): 6070.666666666666
SG&A to revenue (%): 2261.3333333333335
Free cash flow (dilution-adjusted): -5972000
Buyback yield (%): 0
Retained earnings: -313396000
Inventory turnover: 0.13648124191461836
Receivables turnover: 1.4150943396226414
Capitalized R&D asset: 7182050
ROCI (R&D-adjusted, %): -121.53995284881702
Rosenberg metric: 0.009259259259259259
FCF margin (%): -7962.666666666666
Revenue growth (%): 78.57142857142857
Rule of 40 score: -7884.095238095238
Financial ratios for COCH — annual report dated 2025-12-31
Total revenue: 241000
Gross profit: -633000
Operating income: -22270000
Net income: -23756000
Capital expenditures: 179000
Operating cash flow: -18201000
Depreciation & amortization: 302000
Net tangible assets: -11767000
Owner earnings: -23633000
Buffett classification: The Gruesome
Stock price: 0.66
Shares outstanding: 77021110
Book value: -11767000
Market cap (USD): 50833932.6
Debt to equity: -0.07809977054474378
Current ratio: 0.543072132848988
Quick ratio: 0.40935824251859537
Interest coverage ratio: -14.0062893081761
COGS to revenue (%): 362.655601659751
R&D to revenue (%): 5180.912863070539
SG&A to revenue (%): 3797.095435684647
Free cash flow (dilution-adjusted): -19125000
Buyback yield (%): 0
Retained earnings: -313396000
Inventory turnover: 0.5653298835705045
Receivables turnover: 4.547169811320755
Capitalized R&D asset: 22261410
ROCI (R&D-adjusted, %): -105.54032620863
Rosenberg metric: -0.011396011396011397
FCF margin (%): -7935.684647302905
Revenue growth (%): 7.111111111111111
Rule of 40 score: -7928.573536191794
Financial ratios for CPKR.TO — annual report dated 2025-12-31
Total revenue: 1340439416.058394
Gross profit: 184503649.63503647
Operating income: 125398540.1459854
Net income: 77607299.27007298
Capital expenditures: 0
Operating cash flow: 152481751.8248175
Depreciation & amortization: 36356934.30656934
Net tangible assets: 132208759.12408759
Owner earnings: 113964233.57664232
Return on net tangible assets (%): 86.20021421551847
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.467153284671532
P/E ratio: 4.398545411768025
Shares outstanding: 29768437
Book value: 198528467.1532846
P/B ratio: 1.7194472662730165
Market cap (USD): 341359230.1240876
Debt to equity: 1.7822371904229664
Current ratio: 2.664309829892222
Quick ratio: 1.0632125697961305
Effective tax rate (%): 28.04850814446873
Interest coverage ratio: 17.128215353938188
COGS to revenue (%): 86.23558458333197
SG&A to revenue (%): 4.409383130708854
Free cash flow (dilution-adjusted): 150010948.90510947
Buyback yield (%): 89.52595463083289
Retained earnings: 30407299.27007299
Inventory turnover: 6.421839327496643
Receivables turnover: 18.24778163101046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.313603042409824
FCF margin (%): 11.191177095211179
Revenue growth (%): 15.574073212119622
Rule of 40 score: 26.765250307330803
Financial ratios for CPKR.TO — quarterly report dated 2025-12-31
Total revenue: 313436496.3503649
Gross profit: 47870072.992700726
Operating income: 30650364.963503648
Net income: 16910218.97810219
Capital expenditures: 0
Operating cash flow: 35876642.33576642
Depreciation & amortization: 9210218.978102189
Net tangible assets: 132208759.12408759
Owner earnings: 26120437.956204377
Return on net tangible assets (%): 19.75696476485982
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.467153284671532
P/E ratio: 4.829088893721096
Shares outstanding: 29768437
Book value: 198528467.1532846
P/B ratio: 1.7194472662730165
Market cap (USD): 341359230.1240876
Debt to equity: 1.7822371904229664
Current ratio: 2.664309829892222
Quick ratio: 1.0632125697961305
Effective tax rate (%): 28.527796631085334
Interest coverage ratio: 6.234743875278396
COGS to revenue (%): 84.72734555481036
SG&A to revenue (%): 5.493842685744094
Free cash flow (dilution-adjusted): 35562043.795620434
Buyback yield (%): 0
Retained earnings: 30407299.27007299
Inventory turnover: 1.4753630358352157
Receivables turnover: 4.266899847968441
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.4539716020968525
FCF margin (%): 11.34585289514867
Revenue growth (%): -9.573678468791758
Rule of 40 score: 1.7721744263569121
Financial ratios for CRL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 376.78
Shares outstanding: 48167730
Market cap (USD): 18148637309.399998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRL — annual report dated 2022-12-31
Total revenue: 3976060000
Gross profit: 1462651000
Operating income: 650975000
Net income: 492608000
Capital expenditures: 324733000
Operating cash flow: 619640000
Depreciation & amortization: 303870000
Net tangible assets: -828885000
Owner earnings: 471745000
Return on net tangible assets (%): -56.913202675883866
Capex to operating income (%): 49.88409693152579
Buffett classification: The Good
Stock price: 217.9
P/E ratio: 21.306491910403405
Shares outstanding: 48167730
Book value: 3023505000
P/B ratio: 3.471384491509027
Market cap (USD): 10495748367
Debt to equity: 1.0243991658687517
Current ratio: 1.318295872515654
Quick ratio: 1.0839494862974481
Effective tax rate (%): 20.92804504748895
Interest coverage ratio: 10.979322325479416
COGS to revenue (%): 63.213558145500826
SG&A to revenue (%): 16.72756447337314
Free cash flow (dilution-adjusted): 221290000
Buyback yield (%): 0.36825387431661166
Retained earnings: 1432901000
Inventory turnover: 9.825334526932203
Receivables turnover: 5.2845731601961745
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.997796100095451
FCF margin (%): 5.565559875857004
Rule of 40 score: 5.565559875857004
Financial ratios for CRL — annual report dated 2023-12-31
Total revenue: 4129409000
Gross profit: 1502556000
Operating income: 617261000
Net income: 480370000
Capital expenditures: 318528000
Operating cash flow: 683898000
Depreciation & amortization: 314124000
Net tangible assets: -362214000
Owner earnings: 475966000
Return on net tangible assets (%): -131.40463924641236
Capex to operating income (%): 51.60345461644263
Buffett classification: The Good
Stock price: 236.4
P/E ratio: 23.70433493348877
Shares outstanding: 48167730
Book value: 3658998000
P/B ratio: 3.1120135545305025
Market cap (USD): 11386851372
Debt to equity: 0.8380384465911159
Current ratio: 1.5246795983629708
Quick ratio: 1.1642725399542406
Effective tax rate (%): 17.360532889258952
Interest coverage ratio: 4.515112281471729
COGS to revenue (%): 63.61329187784499
SG&A to revenue (%): 18.110460843186036
Free cash flow (dilution-adjusted): 293322000
Buyback yield (%): 0.21213063392920517
Retained earnings: 1887218000
Inventory turnover: 6.9080626625536805
Receivables turnover: 5.291570078487906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.645210120731061
FCF margin (%): 7.103244071972527
Revenue growth (%): 3.856807995855193
Rule of 40 score: 10.96005206782772
Financial ratios for CRL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 196.97
Shares outstanding: 48167730
Market cap (USD): 9487597778.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 184.6
Shares outstanding: 48167730
Market cap (USD): 8891762958
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRL — annual report dated 2024-12-31
Total revenue: 4049989000
Gross profit: 1331821000
Operating income: 442347000
Net income: 25291000
Capital expenditures: 232967000
Operating cash flow: 734577000
Depreciation & amortization: 361741000
Net tangible assets: -108505000
Owner earnings: 154065000
Return on net tangible assets (%): -141.98884844016405
Capex to operating income (%): 52.66611958485081
Buffett classification: The Good
Stock price: 184.6
P/E ratio: 351.5781486694871
Shares outstanding: 48167730
Book value: 3508078000
P/B ratio: 2.5346537214965004
Market cap (USD): 8891762958
Debt to equity: 0.7764918567945183
Current ratio: 1.4113968298995776
Quick ratio: 1.131199948496179
Effective tax rate (%): 72.83867087655992
Interest coverage ratio: 3.502684340554922
COGS to revenue (%): 67.11544154811284
SG&A to revenue (%): 18.543334315229004
Free cash flow (dilution-adjusted): 431719000
Buyback yield (%): 1.3402853918049757
Retained earnings: 1812100000
Inventory turnover: 9.758486989488196
Receivables turnover: 5.617845377055548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.7696737373137585
FCF margin (%): 10.659757347489093
Revenue growth (%): -1.9232776409408707
Rule of 40 score: 8.736479706548222
Financial ratios for CRL — quarterly report dated 2025-03-31
Total revenue: 984168000
Gross profit: 317732000
Operating income: 74669000
Net income: 25878000
Capital expenditures: 59324000
Operating cash flow: 171697000
Depreciation & amortization: 120364000
Net tangible assets: -334771000
Owner earnings: 86918000
Return on net tangible assets (%): -25.963419770529704
Capex to operating income (%): 79.44930292356935
Buffett classification: The Gruesome
Stock price: 150.52
P/E ratio: 70.04218563644795
Shares outstanding: 48167730
Book value: 3241782000
P/B ratio: 2.2364880549031367
Market cap (USD): 7250206719.6
Debt to equity: 0.9210566904252044
Current ratio: 1.433186655312995
Quick ratio: 1.157124983944703
Effective tax rate (%): 28.07271110122853
Interest coverage ratio: 2.6778439248314445
COGS to revenue (%): 67.71567455962804
SG&A to revenue (%): 18.065919639736304
Free cash flow (dilution-adjusted): 99238000
Buyback yield (%): 4.8706473298940995
Retained earnings: 1837569000
Inventory turnover: 2.2968196418478337
Receivables turnover: 1.300727304927514
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1432467386716083
FCF margin (%): 10.08344103852188
Rule of 40 score: 10.08344103852188
Financial ratios for CRL — quarterly report dated 2025-06-30
Total revenue: 1032135000
Gross profit: 357067000
Operating income: 100134000
Net income: 52693000
Capital expenditures: 35298000
Operating cash flow: 204603000
Depreciation & amortization: 119507000
Net tangible assets: -185396000
Owner earnings: 136902000
Return on net tangible assets (%): -73.84301710932274
Capex to operating income (%): 35.2507639762718
Buffett classification: The Good
Stock price: 151.73
P/E ratio: 93.01764866044722
Shares outstanding: 48167730
Book value: 3399586000
P/B ratio: 2.149817558049715
Market cap (USD): 7308489672.9
Debt to equity: 0.8195227301206677
Current ratio: 1.3604316027388892
Quick ratio: 1.1016939426417804
Effective tax rate (%): 26.218880394298356
Interest coverage ratio: 3.341475623185504
COGS to revenue (%): 65.40501000353636
SG&A to revenue (%): 18.558521898782622
Free cash flow (dilution-adjusted): 152256000
Buyback yield (%): 0.100595339516745
Retained earnings: 1889895000
Inventory turnover: 2.4148381327132893
Receivables turnover: 1.3446804130964123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5452522620382656
FCF margin (%): 14.751558662384282
Revenue growth (%): 4.8738629990001705
Rule of 40 score: 19.62542166138445
Financial ratios for CRL — quarterly report dated 2025-09-30
Total revenue: 1004852000
Gross profit: 338792000
Operating income: 133799000
Net income: 55556000
Capital expenditures: 35580000
Operating cash flow: 213826000
Depreciation & amortization: 85164000
Net tangible assets: -87926000
Owner earnings: 105140000
Return on net tangible assets (%): -119.57782680890749
Capex to operating income (%): 26.59212699646485
Buffett classification: The Good
Stock price: 156.46
P/E ratio: 56.18796391330605
Shares outstanding: 48167730
Book value: 3450817000
P/B ratio: 2.1839242810615573
Market cap (USD): 7536323035.8
Debt to equity: 0.761743668238565
Current ratio: 1.3656479078125445
Quick ratio: 1.0959685815339855
Effective tax rate (%): 36.288990825688074
Interest coverage ratio: 5.2670550722355625
COGS to revenue (%): 66.2843881487025
SG&A to revenue (%): 17.67314987679778
Free cash flow (dilution-adjusted): 154979000
Buyback yield (%): 0.0012340235358572023
Retained earnings: 1944317000
Inventory turnover: 2.2014873574615765
Receivables turnover: 1.3681097698786355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.093250795848011
FCF margin (%): 15.423067277569233
Revenue growth (%): -2.643355762569819
Rule of 40 score: 12.779711514999414
Financial ratios for CRL — quarterly report dated 2025-12-31
Total revenue: 994227000
Gross profit: 309684000
Operating income: 92534000
Net income: -276290000
Capital expenditures: 88950000
Operating cash flow: 147520000
Depreciation & amortization: 78277000
Net tangible assets: 60382000
Owner earnings: -286963000
Return on net tangible assets (%): -475.2459342188069
Capex to operating income (%): 96.12682905742754
Buffett classification: The Gruesome
Stock price: 199.48
Shares outstanding: 48167730
Book value: 3211194000
P/B ratio: 2.992188818364758
Market cap (USD): 9608498780.4
Debt to equity: 0.8004524173874266
Current ratio: 1.2916447606253598
Quick ratio: 1.0246635990770454
Interest coverage ratio: 3.8920715036803366
COGS to revenue (%): 68.8517813336391
SG&A to revenue (%): 19.727486781187796
Free cash flow (dilution-adjusted): 40938000
Buyback yield (%): 0.000999115493419499
Retained earnings: 1388620000
Inventory turnover: 2.2886530726873353
Receivables turnover: 1.4025796494633607
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5383599992485586
FCF margin (%): 4.117570735858108
Revenue growth (%): -1.0573696424946162
Rule of 40 score: 3.060201093363492
Financial ratios for CRL — annual report dated 2025-12-31
Total revenue: 4015382000
Gross profit: 1323275000
Operating income: 401136000
Net income: -142163000
Capital expenditures: 219152000
Operating cash flow: 737646000
Depreciation & amortization: 403312000
Net tangible assets: 60382000
Owner earnings: 41997000
Capex to operating income (%): 54.63284272665629
Buffett classification: The Good
Stock price: 199.48
Shares outstanding: 48167730
Book value: 3211194000
P/B ratio: 2.992188818364758
Market cap (USD): 9608498780.4
Debt to equity: 0.8004524173874266
Current ratio: 1.2916447606253598
Quick ratio: 1.0246635990770454
Interest coverage ratio: 3.74791878836577
COGS to revenue (%): 67.04485401388959
SG&A to revenue (%): 18.50566147878334
Free cash flow (dilution-adjusted): 447411000
Buyback yield (%): 3.7536873162301143
Retained earnings: 1388620000
Inventory turnover: 9.000601799380147
Receivables turnover: 5.664594783707834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.668809050279571
FCF margin (%): 11.142426797749255
Revenue growth (%): -0.8544961480142292
Rule of 40 score: 10.287930649735026
Financial ratios for CUU.V — annual report dated 2021-10-31
Capital expenditures: 1512314.6341463416
Buffett classification: The Gruesome
Stock price: 0.22764227642276424
Shares outstanding: 586249986
Market cap (USD): 133455281.36585367
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CUU.V — annual report dated 2022-10-31
Total revenue: 0
Gross profit: -10497.794117647058
Operating income: -751358.0882352941
Net income: -949239.7058823529
Capital expenditures: 0
Operating cash flow: -796808.8235294117
Depreciation & amortization: 10497.794117647058
Net tangible assets: 58179273.52941176
Owner earnings: -938741.9117647058
Return on net tangible assets (%): -1.6135332306790273
Buffett classification: The Gruesome
Stock price: 0.13235294117647056
Shares outstanding: 586249986
Book value: 58179273.52941176
P/B ratio: 1.333669281252526
Market cap (USD): 77591909.9117647
Debt to equity: 0.009245130909516848
Current ratio: 0.495335391332526
Quick ratio: 0.495335391332526
Free cash flow (dilution-adjusted): -1762214.7058823528
Buyback yield (%): 0
Retained earnings: -20133044.852941174
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.266986028841986
Rule of 40 score: 0
Financial ratios for CUU.V — annual report dated 2023-10-31
Total revenue: 0
Gross profit: -12088.40579710145
Operating income: -819228.2608695653
Net income: -807617.3913043479
Capital expenditures: 12215.942028985508
Operating cash flow: -724280.4347826088
Depreciation & amortization: 12088.40579710145
Net tangible assets: 59574864.492753625
Owner earnings: -807744.9275362319
Return on net tangible assets (%): -1.355848535139315
Buffett classification: The Gruesome
Stock price: 0.11594202898550726
Shares outstanding: 586249986
Book value: 59574864.49275363
P/B ratio: 1.1409344099781016
Market cap (USD): 67971012.86956523
Debt to equity: 0.0054588604159523406
Current ratio: 2.6904544578754077
Quick ratio: 2.6904544578754077
Free cash flow (dilution-adjusted): -1768857.971014493
Buyback yield (%): 0
Retained earnings: -20648878.98550725
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3555416255300596
Rule of 40 score: 0
Financial ratios for CUU.V — annual report dated 2024-10-31
Total revenue: 0
Gross profit: -9678.41726618705
Operating income: -800748.201438849
Net income: -436908.6330935252
Capital expenditures: 0
Operating cash flow: -773882.0143884893
Depreciation & amortization: 9678.41726618705
Net tangible assets: 60274024.46043166
Owner earnings: -427230.21582733816
Return on net tangible assets (%): -0.708813157329164
Buffett classification: The Gruesome
Stock price: 0.20143884892086333
Shares outstanding: 586249986
Book value: 60274024.46043166
P/B ratio: 1.9592772079992367
Market cap (USD): 118093522.35971224
Debt to equity: 0.0010179409162189175
Current ratio: 4.743310556407754
Quick ratio: 4.743310556407754
Free cash flow (dilution-adjusted): -1784579.1366906476
Buyback yield (%): 0
Retained earnings: -20937234.532374103
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3179863034527999
Rule of 40 score: 0
Financial ratios for CUU.V — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.20143884892086333
Shares outstanding: 586249986
Market cap (USD): 118093522.35971224
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CUU.V — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: -2286.896551724138
Operating income: -164994.4827586207
Net income: -163422.06896551725
Capital expenditures: 328075.1724137931
Operating cash flow: -103146.89655172414
Depreciation & amortization: 2286.896551724138
Net tangible assets: 58098026.89655173
Owner earnings: -489210.3448275862
Return on net tangible assets (%): -0.8420429590468969
Buffett classification: The Gruesome
Stock price: 0.1724137931034483
Shares outstanding: 586249986
Book value: 58098026.89655172
P/B ratio: 1.7397765327397494
Market cap (USD): 101077583.79310346
Debt to equity: 0.0009857893090772542
Current ratio: 1.1270795548123411
Quick ratio: 1.1270795548123411
Free cash flow (dilution-adjusted): -431222.0689655173
Buyback yield (%): 0
Retained earnings: -20234288.275862068
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2817626658378897
Rule of 40 score: 0
Financial ratios for CUU.V — quarterly report dated 2025-04-30
Total revenue: 0
Gross profit: -2402.898550724638
Operating income: -272366.6666666667
Net income: -271056.52173913043
Capital expenditures: 171609.42028985507
Operating cash flow: -316850
Depreciation & amortization: 2402.1739130434785
Net tangible assets: 61230852.89855073
Owner earnings: -440263.768115942
Return on net tangible assets (%): -0.7190227594010251
Buffett classification: The Gruesome
Stock price: 0.17391304347826086
Shares outstanding: 586249986
Book value: 61230852.89855073
P/B ratio: 1.6651167585934612
Market cap (USD): 101956519.30434783
Debt to equity: 0.0009552823593703833
Current ratio: 7.072332181531656
Quick ratio: 7.072332181531656
Free cash flow (dilution-adjusted): -488459.4202898551
Buyback yield (%): 0
Retained earnings: -21531722.463768117
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4413481030683196
Rule of 40 score: 0
Financial ratios for CUU.V — quarterly report dated 2025-07-31
Total revenue: 0
Gross profit: -2402.898550724638
Operating income: -217314.4927536232
Net income: -214260.14492753625
Capital expenditures: 0
Operating cash flow: 167163.76811594205
Depreciation & amortization: 2403.6231884057975
Net tangible assets: 61366663.768115945
Owner earnings: -211856.52173913046
Return on net tangible assets (%): -0.3452306329372332
Buffett classification: The Gruesome
Stock price: 0.1884057971014493
Shares outstanding: 586249986
Book value: 61366663.768115945
P/B ratio: 1.799884320425304
Market cap (USD): 110452895.9130435
Debt to equity: 0.0009246747242601952
Current ratio: 1.29446443418676
Quick ratio: 1.29446443418676
Free cash flow (dilution-adjusted): 683489.8550724639
Buyback yield (%): 0
Retained earnings: -21745981.884057973
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3513771965204924
Rule of 40 score: 0
Financial ratios for CUU.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: -2368.571428571429
Operating income: -240924.28571428574
Net income: -117527.14285714287
Capital expenditures: 0
Operating cash flow: -571405
Depreciation & amortization: 2368.571428571429
Net tangible assets: 61395092.85714286
Owner earnings: -115158.57142857143
Return on net tangible assets (%): -0.1875696673291595
Buffett classification: The Gruesome
Stock price: 0.29285714285714287
Shares outstanding: 586249986
Book value: 61395092.857142866
P/B ratio: 2.796436781999678
Market cap (USD): 171687495.9
Debt to equity: 0.0008818992397368193
Current ratio: 1.7871823058880745
Quick ratio: 1.7871823058880745
Free cash flow (dilution-adjusted): -1965130.7142857143
Buyback yield (%): 0
Retained earnings: -21552852.142857146
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3902038918122245
Rule of 40 score: 0